Cargando…
Prevalent, persistent, and impairing: Longitudinal course and impact of apathy in Alzheimer's disease
INTRODUCTION: Understanding of the natural history of apathy and its impact on patient function is limited. This study examines, in a large, national sample of Alzheimer's disease (AD) patients with long follow‐ups: (1) prevalence, incidence, and persistence of apathy, and (2) impact of apathy...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817116/ https://www.ncbi.nlm.nih.gov/pubmed/35141391 http://dx.doi.org/10.1002/dad2.12169 |
_version_ | 1784645568247627776 |
---|---|
author | Grossman, Hillel T. Sano, Mary Aloysi, Amy Elder, Gregory A. Neugroschl, Judith Schimming, Corbett Soleimani, Laili Zhu, Carolyn W. |
author_facet | Grossman, Hillel T. Sano, Mary Aloysi, Amy Elder, Gregory A. Neugroschl, Judith Schimming, Corbett Soleimani, Laili Zhu, Carolyn W. |
author_sort | Grossman, Hillel T. |
collection | PubMed |
description | INTRODUCTION: Understanding of the natural history of apathy and its impact on patient function is limited. This study examines, in a large, national sample of Alzheimer's disease (AD) patients with long follow‐ups: (1) prevalence, incidence, and persistence of apathy, and (2) impact of apathy on function across dementia severity. METHODS: A longitudinal study of 9823 well‐characterized AD patients in the National Alzheimer's Coordinating Center Uniform Data Set. RESULTS: Apathy was highly prevalent across disease severity with cumulative prevalence of 48%, 74%, and 82% in Clinical Dementia Rating (CDR) 0.5, 1.0, and 2.0, respectively. Persistence of apathy from clinician judgment varied from visit to visit at earlier disease stages but remained high at moderate dementia. Independent of cognition, persistent apathy was strongly associated with accelerated rate of functional decline. DISCUSSION: Findings point to important targets for the treatment and management of apathy, include functional outcomes, and study designs that account for variable persistence of the apathy syndrome. |
format | Online Article Text |
id | pubmed-8817116 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88171162022-02-08 Prevalent, persistent, and impairing: Longitudinal course and impact of apathy in Alzheimer's disease Grossman, Hillel T. Sano, Mary Aloysi, Amy Elder, Gregory A. Neugroschl, Judith Schimming, Corbett Soleimani, Laili Zhu, Carolyn W. Alzheimers Dement (Amst) Cognitive & Behavioral Assessment INTRODUCTION: Understanding of the natural history of apathy and its impact on patient function is limited. This study examines, in a large, national sample of Alzheimer's disease (AD) patients with long follow‐ups: (1) prevalence, incidence, and persistence of apathy, and (2) impact of apathy on function across dementia severity. METHODS: A longitudinal study of 9823 well‐characterized AD patients in the National Alzheimer's Coordinating Center Uniform Data Set. RESULTS: Apathy was highly prevalent across disease severity with cumulative prevalence of 48%, 74%, and 82% in Clinical Dementia Rating (CDR) 0.5, 1.0, and 2.0, respectively. Persistence of apathy from clinician judgment varied from visit to visit at earlier disease stages but remained high at moderate dementia. Independent of cognition, persistent apathy was strongly associated with accelerated rate of functional decline. DISCUSSION: Findings point to important targets for the treatment and management of apathy, include functional outcomes, and study designs that account for variable persistence of the apathy syndrome. John Wiley and Sons Inc. 2022-02-05 /pmc/articles/PMC8817116/ /pubmed/35141391 http://dx.doi.org/10.1002/dad2.12169 Text en © 2021 The Authors. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals, LLC on behalf of Alzheimer's Association https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Cognitive & Behavioral Assessment Grossman, Hillel T. Sano, Mary Aloysi, Amy Elder, Gregory A. Neugroschl, Judith Schimming, Corbett Soleimani, Laili Zhu, Carolyn W. Prevalent, persistent, and impairing: Longitudinal course and impact of apathy in Alzheimer's disease |
title | Prevalent, persistent, and impairing: Longitudinal course and impact of apathy in Alzheimer's disease |
title_full | Prevalent, persistent, and impairing: Longitudinal course and impact of apathy in Alzheimer's disease |
title_fullStr | Prevalent, persistent, and impairing: Longitudinal course and impact of apathy in Alzheimer's disease |
title_full_unstemmed | Prevalent, persistent, and impairing: Longitudinal course and impact of apathy in Alzheimer's disease |
title_short | Prevalent, persistent, and impairing: Longitudinal course and impact of apathy in Alzheimer's disease |
title_sort | prevalent, persistent, and impairing: longitudinal course and impact of apathy in alzheimer's disease |
topic | Cognitive & Behavioral Assessment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817116/ https://www.ncbi.nlm.nih.gov/pubmed/35141391 http://dx.doi.org/10.1002/dad2.12169 |
work_keys_str_mv | AT grossmanhillelt prevalentpersistentandimpairinglongitudinalcourseandimpactofapathyinalzheimersdisease AT sanomary prevalentpersistentandimpairinglongitudinalcourseandimpactofapathyinalzheimersdisease AT aloysiamy prevalentpersistentandimpairinglongitudinalcourseandimpactofapathyinalzheimersdisease AT eldergregorya prevalentpersistentandimpairinglongitudinalcourseandimpactofapathyinalzheimersdisease AT neugroschljudith prevalentpersistentandimpairinglongitudinalcourseandimpactofapathyinalzheimersdisease AT schimmingcorbett prevalentpersistentandimpairinglongitudinalcourseandimpactofapathyinalzheimersdisease AT soleimanilaili prevalentpersistentandimpairinglongitudinalcourseandimpactofapathyinalzheimersdisease AT zhucarolynw prevalentpersistentandimpairinglongitudinalcourseandimpactofapathyinalzheimersdisease |